In the study, patients with DecisionDx-SCC Class 2B test results, predicted to have the highest risk of metastasis by the test, who were treated with adjuvant radiation therapy (ART) had 50% higher ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback